> MM120 is a tartrate salt form of lysergide, a semi-synthetic hallucinogen commonly known as LSD
> MM120 is a tartrate salt form of lysergide, a semi-synthetic hallucinogen commonly known as LSD
For d-amphetamine making it a salt produces an effect similar to delayed release. The result is sold as a “more modern” ADHD treatment Vyvanse.
So is this achieving similar effect? Flattening the curve, so to speak?
Or maybe it’s just to distance itself from the recreational LSD culture?
And with LSD freebase that's not an unnecessary luxury, as it isn't the most stable against decomposition. To answer the question... probably this is the most stable formulation to get it into a pharmacy? I guess like you say, not blatantly calling it LSD helps image building too.
With vyvanse, that's actually something else: not a salt but an amino acid covalently bound to amphetamine. This gives a much stronger bond than between tartrate and lsd ions in the salt, one that can be hydrolysed slowly in the gut to produce the active drug. LSD tartrate doesn't have a similar slow release property.
The salt is patentable.
Amazingly, I found a Swiss clinical trial from 2021 (!) comparing the pharmacokinetics of the freebase vs. tartarate in human subjects: https://classic.clinicaltrials.gov/ct2/show/NCT04865653
Switzerland is (free)based.
Though, I am sure prescription drugs will always be legal with a prescription, assuming the prescription itself is legal. Even if this were counted as the Schedule I drug LSD that can't be prescribed, it'll probably get moved to Schedule II or III before any actual prescriptions are given out. So anyone who ever gets such a prescription in-hand will always be safe.
I'd support decriminalization efforts instead: we let people with cancer get weed from a dispensary.
Why not let veterans and other people with a generalized anxiety disorder get LSD the same way?